Malignant thyroid tumors have been increasing in incidence in the Western world. More than 80% of these are papillary carcinomas which usually have an excellent prognosis.

In recent years important changes have emerged in this context. From ultrasound stratification to histological classification, from parenchymal sparing surgery to active surveillance strategy, from ablative therapy to endoscopic surgery, there are many novelties in the diagnosis and treatment of these tumors.

The bigger question today is how to distinguish aggressive papillary carcinomas from the majority that are indolent and easily treatable?

What is the prognosis of those that recur? is it different from those initially treated aggressively?

This is a meeting with experts from all over Europe where we will try to present new trends and answer these important questions. 

Purpose of this Event:

At the end of the Event, participants should be able to know and discuss the novelties in the diagnosis and treatment of malignant thyroid tumors.

Participants:

• Residents and Physicians of General Surgery, Endocrinology, Otorhinolaryngology, Nuclear Medicine. 

Duration:

The Event lasts approximately 8 hours.

Cancellation of Registration 

Cancellation Fees Up 2 weeks before the date of the Event - reimbursement of 100% of the registration fee. After this period there will be no refund.

Is reserved to Hospital da Luz Learning Health the right to cancel this Event and the attendees are informed in a timely manner and reimbursed 100%. 

Covid-19 Policy

Hospital da Luz Learning Health complies with the guidelines of health authorities and implements all hygiene and safety measures, ensuring the commitment and respect for the health and safety of all in the context of the COVID-19 pandemic.

Other information

For more information about the course, click above on the "Program" button.